LCK and melanoma: In contrast to melanoma, inhibition of Lck has been proposed to counteract psoriatic inflammation based on amelioration of clinical features, attenuation of Th17 immune responses and upregulation of Tregs in IMQ-treated mice treated with the Lck inhibitor, A-770041 [45].